Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Chemotherapy Plus Bevacizumab as Neoadjuvant or Conversion Treatment in Patients with Colorectal Liver Metastases.

García-Alfonso P, Cavanagh Podesta M, Muñoz Martín A, Blanco Codeisido M, Calvo A, Peligros I, Corcuera A, Belén Rúperez Blanco A, Custodio-Cabello S, López Trabada D, Martín M, DE Ramón E.

Anticancer Res. 2018 May;38(5):3069-3077.

PMID:
29715142
2.

Effect of ethnicity on clinical presentation and risk of antiphospholipid syndrome in Roma and Caucasian patients with systemic lupus erythematosus: a multicenter cross-sectional study.

Manzano-Gamero V, Pardo-Cabello AJ, Vargas-Hitos JA, Zamora-Pasadas M, Navarrete-Navarrete N, Sabio JM, Jáimez-Gámiz L, Ríos-Fernandez R, Ortego-Centeno N, Ayala-Gutierrez MM, de Ramón E, Colodro-Ruíz A, Micó-Giner L, Castillo-Palma MJ, Robles-Marhuenda Á, Luna-Del Castillo JD, Jiménez-Alonso J; Spanish Autoimmune Diseases Study Group (GEAS).

Int J Rheum Dis. 2018 Nov;21(11):2028-2035. doi: 10.1111/1756-185X.13117. Epub 2017 Jun 7.

PMID:
28593703
3.

Bronchiolitis obliterans organizing pneumonia in patients with autoimmune rheumatic diseases.

Rojas CM, Borella E, Palma L, Ragozzino S, De Ramón E, Gomez-Huelgas R, Punzi L, Doria A.

Immunol Res. 2015 Feb;61(1-2):97-103. doi: 10.1007/s12026-014-8607-z. Review.

PMID:
25480740
4.

Analysis of ancestral and functionally relevant CD5 variants in systemic lupus erythematosus patients.

Cenit MC, Martínez-Florensa M, Consuegra M, Bonet L, Carnero-Montoro E, Armiger N, Caballero-Baños M, Arias MT, Benitez D, Ortego-Centeno N, de Ramón E, Sabio JM, García-Hernández FJ, Tolosa C, Suárez A, González-Gay MA, Bosch E, Martín J, Lozano F.

PLoS One. 2014 Nov 17;9(11):e113090. doi: 10.1371/journal.pone.0113090. eCollection 2014.

5.

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.

Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M, Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de Groot PG, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Fernández-Nebro A, Haro M, Amoura Z, Miyara M, Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA; Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies).

Ann Rheum Dis. 2015 Jun;74(6):1011-8. doi: 10.1136/annrheumdis-2013-204838. Epub 2014 Jan 24.

6.

No evidence of association between common autoimmunity STAT4 and IL23R risk polymorphisms and non-anterior uveitis.

Cénit MC, Márquez A, Cordero-Coma M, Gorroño-Echebarría MB, Fonollosa A, Adán A, Martínez-Berriotxoa A, Díaz Valle D, Pato E, Blanco R, Cañal J, Díaz-Llopis M, García Serrano JL, de Ramón E, Del Rio MJ, Martín-Villa JM, Molins B, Ortego-Centeno N, Martín J.

PLoS One. 2013 Nov 29;8(11):e72892. doi: 10.1371/journal.pone.0072892. eCollection 2013.

7.

Two functional variants of IRF5 influence the development of macular edema in patients with non-anterior uveitis.

Márquez A, Cénit MC, Cordero-Coma M, Ortego-Centeno N, Adán A, Fonollosa A, Díaz Valle D, Pato E, Blanco R, Cañal J, Díaz-Llopis M, de Ramón E, Del Rio MJ, García Serrano JL, Artaraz J, Martín-Villa JM, Llorenç V, Gorroño-Echebarría MB, Martín J.

PLoS One. 2013 Oct 7;8(10):e76777. doi: 10.1371/journal.pone.0076777. eCollection 2013.

8.

Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition.

Cénit MC, Márquez A, Cordero-Coma M, Fonollosa A, Adán A, Martínez-Berriotxoa A, Llorenç V, Díaz Valle D, Blanco R, Cañal J, Díaz-Llopis M, García Serrano JL, de Ramón E, del Rio MJ, Begoña Gorroño-Echebarría M, Martín-Villa JM, Ortego-Centeno N, Martín J.

BMC Med Genet. 2013 May 15;14:52. doi: 10.1186/1471-2350-14-52.

9.

Evidence of new risk genetic factor to systemic lupus erythematosus: the UBASH3A gene.

Diaz-Gallo LM, Sánchez E, Ortego-Centeno N, Sabio JM, García-Hernández FJ, de Ramón E, González-Gay MA, Torsten Witte, Anders HJ, González-Escribano MF, Martin J.

PLoS One. 2013;8(4):e60646. doi: 10.1371/journal.pone.0060646. Epub 2013 Apr 2.

10.

Lack of association between the protein tyrosine phosphatase non-receptor type 22 R263Q and R620W functional genetic variants and endogenous non-anterior uveitis.

Cénit MC, Márquez A, Cordero-Coma M, Fonollosa A, Llorenç V, Artaraz J, Díaz Valle D, Blanco R, Cañal J, Salom D, García Serrano JL, de Ramón E, José del Rio M, Gorroño-Echebarría MB, Martín-Villa JM, Molins B, Ortego-Centeno N, Martín J.

Mol Vis. 2013;19:638-43. Epub 2013 Mar 20.

11.

Fine mapping and conditional analysis identify a new mutation in the autoimmunity susceptibility gene BLK that leads to reduced half-life of the BLK protein.

Delgado-Vega AM, Dozmorov MG, Quirós MB, Wu YY, Martínez-García B, Kozyrev SV, Frostegård J, Truedsson L, de Ramón E, González-Escribano MF, Ortego-Centeno N, Pons-Estel BA, D'Alfonso S, Sebastiani GD, Witte T, Lauwerys BR, Endreffy E, Kovács L, Vasconcelos C, da Silva BM, Wren JD, Martin J, Castillejo-López C, Alarcón-Riquelme ME.

Ann Rheum Dis. 2012 Jul;71(7):1219-26. doi: 10.1136/annrheumdis-2011-200987.

12.

Association study of IRAK-M and SIGIRR genes with SLE in a large European-descent population.

Sánchez E, García-Bermúdez M, Jiménez-Alonso J, de Ramón E, Sánchez-Román J, Ortego-Centeno N, Witte T, D'Alfonso S, Pons-Estel B, Anders HJ, Alarcón-Riquelme ME, Martín J.

Lupus. 2012 Oct;21(11):1166-71. doi: 10.1177/0961203312449494. Epub 2012 May 25.

PMID:
22634523
13.

[Normalisation and validation of the Brief Neuropsychological Battery as the reference neuropsychological test in multiple sclerosis].

Duque P, Ibanez J, Del Barco A, Sepulcre J, de Ramon E, Fernandez-Fernandez O; grupo de estudio de la Batería Neuropsicológica Breve en la Esclerosis Múltiple (BNBEM.

Rev Neurol. 2012 Mar 1;54(5):263-70. Spanish.

14.

Novel association of acid phosphatase locus 1*C allele with systemic lupus erythematosus.

Teruel M, Martin JE, Ortego-Centeno N, Jiménez-Alonso J, Sánchez-Román J, de Ramón E, Gonzalez-Escribano MF, Pons-Estel BA, D'Alfonso S, Sebastiani GD, Witte T, Bottini N, González-Gay MA, Alarcón-Riquelme ME, Martin J.

Hum Immunol. 2012 Jan;73(1):107-10. doi: 10.1016/j.humimm.2011.10.012. Epub 2011 Oct 21. Erratum in: Hum Immunol. 2012 Sep;73(9):984.

PMID:
22064183
15.

Multiple sclerosis prevalence in Malaga, Southern Spain estimated by the capture-recapture method.

Fernández O, Fernández V, Guerrero M, León A, López-Madrona JC, Alonso A, Bustamante R, Tamayo JA, Romero F, Bravo M, Luque G, García L, Sanchís G, San Roman C, Romero M, Papais-Alvarenga M, de Ramon E.

Mult Scler. 2012 Mar;18(3):372-6. doi: 10.1177/1352458511421917. Epub 2011 Aug 30.

PMID:
21878452
16.

Association study of BAK1 gene polymorphisms in Spanish rheumatoid arthritis and systemic lupus erythematosus cohorts.

Díaz-Gallo LM, Garcia S, Ortego-Centeno N, Jiménez-Alonso J, Sánchez-Román J, de Ramón E, González-Escribano MF, Balsa A, Fernández-Gutierrez B, González-Alvaro I, González-Gay MA, Martin J.

Ann Rheum Dis. 2012 Feb;71(2):314-6. doi: 10.1136/annrheumdis-2011-200062. Epub 2011 Aug 17. No abstract available.

PMID:
21852253
17.

The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an observational study.

Fernández O, Alvarenga MP, Guerrero M, León A, Alonso A, López-Madrona JC, Leyva L, Oliver B, de Ramón E, Luque G, Fernández V.

Mult Scler. 2011 Feb;17(2):192-7. doi: 10.1177/1352458510385507. Epub 2010 Nov 18.

PMID:
21088044
18.

[Impact of melanoma diagnosis on sun protection].

Gómez-Moyano E, de Ramón E, Martínez-García S, Gómez R, Crespo-Erchiga V, Crespo A, Ojeda A.

Actas Dermosifiliogr. 2010 Jul;101(6):506-16. Spanish.

PMID:
20738969
19.

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.

Ramos-Casals M, García-Hernández FJ, de Ramón E, Callejas JL, Martínez-Berriotxoa A, Pallarés L, Caminal-Montero L, Selva-O'Callaghan A, Oristrell J, Hidalgo C, Pérez-Alvarez R, Micó ML, Medrano F, Gómez de la Torre R, Díaz-Lagares C, Camps M, Ortego N, Sánchez-Román J; BIOGEAS Study Group.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4):468-76. Epub 2010 Aug 30.

PMID:
20525449
20.

Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (the Novo Study).

Fernández O, Fernández V, Arbizu T, Izquierdo G, Bosca I, Arroyo R, García Merino JA, de Ramón E; Novo Group.

J Neurol. 2010 Sep;257(9):1500-7. doi: 10.1007/s00415-010-5560-1. Epub 2010 Apr 10.

PMID:
20383518
21.

Association of an NKG2D gene variant with systemic lupus erythematosus in two populations.

Kabalak G, Thomas RM, Martin J, Ortego-Centeno N, Jimenez-Alonso J, de Ramón E, Buyny S, Hamsen S, Gross WL, Schnarr S, Zeidler H, Gromnica-Ihle E, Schmidt RE, Witte T.

Hum Immunol. 2010 Jan;71(1):74-8. doi: 10.1016/j.humimm.2009.09.352.

PMID:
19735685
22.

Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus.

Sánchez E, Palomino-Morales RJ, Ortego-Centeno N, Jiménez-Alonso J, González-Gay MA, López-Nevot MA, Sánchez-Román J, de Ramón E, González-Escribano MF, Pons-Estel BA, D'Alfonso S, Sebastiani GD; Italian collaborative group, Alarcón-Riquelme ME, Martín J.

Hum Mol Genet. 2009 Oct 1;18(19):3739-48. doi: 10.1093/hmg/ddp301. Epub 2009 Jul 7.

PMID:
19584085
23.

Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus.

Sánchez E, Callejas-Rubio JL, Sabio JM, Gónzalez-Gay MA, Jimenez-Alonso J, Micó L, de Ramón E, Camps M, Suarez A, Gutierrez C, Garcia-Portales R, Tolosa C, Ortego-Centeno N, Sánchez-Román J, Garcia-Hernández FJ, Gónzalez-Escribano MF, Martin J.

Clin Exp Rheumatol. 2009 Mar-Apr;27(2):267-71.

PMID:
19473567
24.

Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans.

Liu K, Li QZ, Delgado-Vega AM, Abelson AK, Sánchez E, Kelly JA, Li L, Liu Y, Zhou J, Yan M, Ye Q, Liu S, Xie C, Zhou XJ, Chung SA, Pons-Estel B, Witte T, de Ramón E, Bae SC, Barizzone N, Sebastiani GD, Merrill JT, Gregersen PK, Gilkeson GG, Kimberly RP, Vyse TJ, Kim I, D'Alfonso S, Martin J, Harley JB, Criswell LA; Profile Study Group; Italian Collaborative Group; German Collaborative Group; Spanish Collaborative Group; Argentinian Collaborative Group; SLEGEN Consortium, Wakeland EK, Alarcón-Riquelme ME, Mohan C.

J Clin Invest. 2009 Apr;119(4):911-23. doi: 10.1172/JCI36728.

25.

No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus.

Sánchez E, González-Gay MA, Callejas-Rubio JL, Ortego-Centeno N, Sabio JM, Jiménez-Alonso J, Micó L, Suarez A, Gutierrez C, de Ramón E, Camps M, Garcia-Portales R, Tolosa C, López-Nevot MA, Sánchez-Román J, Hernández FJ, González-Escribano MF, Martín J.

Lupus. 2009 Mar;18(3):230-4. doi: 10.1177/0961203308096256.

PMID:
19213861
26.

Multiple sclerosis in Gypsies from southern Spain: prevalence, mitochondrial DNA haplogroups and HLA class II association.

Fernández O, Fernández V, Martinez-Cabrera V, Mayorga C, Alonso A, León A, Arnal C, Hens M, Luque G, de Ramón E, Caballero A, Leyva L.

Tissue Antigens. 2008 May;71(5):426-33. doi: 10.1111/j.1399-0039.2008.01016.x. Epub 2008 Feb 28.

PMID:
18312478
27.

[Rituximab as treatment for thrombocytopenic thrombotic purpura associated with systemic lupus erythematosus].

López Carmona D, Pérez de Pedro I, de Ramón E, Camps García MT.

Med Clin (Barc). 2007 Dec 1;129(20):797-8. Spanish. No abstract available.

PMID:
18093482
28.

Study of two polymorphisms of the MHC2TA gene with systemic lupus erythematosus.

Sánchez E, Sabio JM, Jiménez-Alonso J, Callejas JL, Camps M, de Ramón E, García-Portales R, de Haro M, Ortego-Centeno N, López-Nevot MA, Martín J.

Rheumatology (Oxford). 2008 Jan;47(1):102-3. Epub 2007 Oct 23. No abstract available.

PMID:
17956914
29.

Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus.

Sánchez E, Abelson AK, Sabio JM, González-Gay MA, Ortego-Centeno N, Jiménez-Alonso J, de Ramón E, Sánchez-Román J, López-Nevot MA, Gunnarsson I, Svenungsson E, Sturfelt G, Truedsson L, Jönsen A, González-Escribano MF, Witte T; German Systemic Lupus Erythematosus Study Group, Alarcón-Riquelme ME, Martín J.

Arthritis Rheum. 2007 Sep;56(9):3080-6.

30.

MYO9B gene polymorphisms are associated with autoimmune diseases in Spanish population.

Sánchez E, Alizadeh BZ, Valdigem G, Ortego-Centeno N, Jiménez-Alonso J, de Ramón E, García A, López-Nevot MA, Wijmenga C, Martín J, Koeleman BP.

Hum Immunol. 2007 Jul;68(7):610-5. Epub 2007 Apr 10.

PMID:
17584584
31.

[Intravenous cyclophosphamide in lupus nephritis: twenty years reducing dose].

Frutos MA, Martín Gómez A, de Ramón E, Camps MT, Valera A, García I, Fernández Nebro A.

Nefrologia. 2007;27(1):12-22. Spanish.

32.

Interferon receptor expression in multiple sclerosis patients.

Oliver B, Mayorga C, Fernández V, Leyva L, León A, Luque G, López JC, Tamayo JA, Pinto-Medel MJ, de Ramon E, Blanco E, Alonso A, Fernández O.

J Neuroimmunol. 2007 Feb;183(1-2):225-31. Epub 2006 Dec 26.

PMID:
17188754
33.

Study of a functional polymorphism in the p53 gene in systemic lupus erythematosus: lack of replication in a Spanish population.

Sánchez E, Sabio JM, Callejas JL, de Ramón E, de Haro M, Jiménez-Alonso J, Ortego-Centeno N, Sánchez-Román J, González-Gay MA, López-Nevot MA, González-Escribano MF, Martín J.

Lupus. 2006;15(10):658-61.

PMID:
17120592
34.

[Interferon-beta response in multiple sclerosis associated with pre-treatment disability].

Fernandez-Fernandez O, Fernandez-Sanchez VE, Mayorga C, Guerrero-Fernandez M, Leon A, Tamayo-Toledo JA, Alonso A, Romero F, Leyva L, Luque G, de Ramon E.

Rev Neurol. 2006 Sep 16-30;43(6):322-9. Spanish.

35.

Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus.

Sánchez E, Gómez LM, Lopez-Nevot MA, González-Gay MA, Sabio JM, Ortego-Centeno N, de Ramón E, Anaya JM, González-Escribano MF, Koeleman BP, Martín J.

Genes Immun. 2006 Jul;7(5):433-6. Epub 2006 May 18.

PMID:
16724072
36.

Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus.

Sánchez E, Sabio JM, Callejas JL, de Ramón E, Garcia-Portales R, García-Hernández FJ, Jiménez-Alonso J, González-Escribano MF, Martín J, Koeleman BP.

BMC Med Genet. 2006 May 23;7:48.

37.

Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients.

Sanchez E, Callejas JL, Sabio JM, de Haro M, Camps M, de Ramón E, García-Hernández FJ, Koeleman B, Martín J, González-Escribano MF.

Rheumatology (Oxford). 2006 Aug;45(8):1044-6. Epub 2006 May 22. No abstract available.

PMID:
16717063
38.

No primary association of MICA polymorphism with systemic lupus erythematosus.

Sánchez E, Torres B, Vilches JR, López-Nevot MA, Ortego-Centeno N, Jiménez-Alonso J, González-Gay MA, de Ramón E, Sánchez-Román J, Núñez-Roldán A, Martín J, González-Escribano MF.

Rheumatology (Oxford). 2006 Sep;45(9):1096-100. Epub 2006 Mar 14.

PMID:
16537577
39.

Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project".

Cervera R, Abarca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, Bacarelli MR, Bellisai F, Bernardino I, Biernat-Kaluza E, Blockmans D, Boki K, Bracci L, Campanella V, Camps MT, Carcassi C, Cattaneo R, Cauli A, Cervera R, Chwalinska-Sadowska H, Contu L, Cosyns JP, Danieli MG, DCruz D, Depresseux G, Direskeneli H, Domènech I, Espinosa G, Fernández-Nebro A, Ferrara GB, Font J, Frutos MA, Galeazzi M, Garcìa-Carrasco M, García Iglesias MF, García-Tobaruela A, George J, Gil A, González-Santos P, Grana M, Gül A, Haga HJ, de Haro-Liger M, Houssiau F, Hughes GR, Ingelmo M, Jedryka-Góral A, Khamashta MA, Lavilla P, Levi Y, López-Dulpa M, López-Soto A, Maldykowa H, Marcolongo R, Mathieu A, Morozzi G, Nicolopoulou N, Papasteriades C, Passiu G, Perelló I, Petera P, Petrovic R, Piette JC, Pintado V, de Pita O, Popovic R, Pucci G, Puddu P, de Ramón E, Ramos-Casals M, Rodríguez-Andreu J, Ruiz-Irastorza G, Sanchez-Lora J, Sanna G, Scorza R, Sebastiani GD, Sherer Y, Shoenfeld Y, Simpatico A, Sinico RA, Smolen J, Tincani A, Tokgöz G, Urbano-Márquez A, Vasconcelos C, Vázquez JJ, Veronesi J, Vianna J, Vivancos J; European Working Party on Systemic Lupus Erythematosus.

Autoimmun Rev. 2006 Mar;5(3):180-6. Epub 2005 Jul 26. Review.

PMID:
16483917
40.

HLA class II and response to interferon-beta in multiple sclerosis.

Fernández O, Fernández V, Mayorga C, Guerrero M, León A, Tamayo JA, Alonso A, Romero F, Leyva L, Alonso A, Luque G, de Ramón E.

Acta Neurol Scand. 2005 Dec;112(6):391-4.

PMID:
16281922
41.

Study of the role of functional variants of SLC22A4, RUNX1 and SUMO4 in systemic lupus erythematosus.

Orozco G, Sánchez E, Gómez LM, González-Gay MA, López-Nevot MA, Torres B, Ortego-Centeno N, Jiménez-Alonso J, de Ramón E, Sánchez Román J, Anaya JM, Sturfelt G, Gunnarsson I, Svennungsson E, Alarcón-Riquelme M, González-Escribano MF, Martín J.

Ann Rheum Dis. 2006 Jun;65(6):791-5. Epub 2005 Oct 25.

42.

Systemic lupus erythematosus in southern Spain: a comparative clinical and genetic study between Caucasian and Gypsy patients.

Ramal LM, López-Nevot MA, Sabio JM, Jáimez L, Paco L, Sánchez J, de Ramón E, Fernández-Nebro A, Ortego N, Ruiz-Cantero A, Rivera F, Martín J, Jiménez-Alonso J; Grupo Lupus Virgen de las Nieves.

Lupus. 2004;13(12):934-40.

PMID:
15645749
43.

Azathioprine and methotrexate in multiple sclerosis.

Fernández O, Fernández V, De Ramón E.

J Neurol Sci. 2004 Aug 15;223(1):29-34. Review.

PMID:
15261557
44.

DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.

Fernández O, Fernández V, Alonso A, Caballero A, Luque G, Bravo M, León A, Mayorga C, Leyva L, de Ramón E.

J Neurol. 2004 Apr;251(4):440-4.

PMID:
15083289
45.

Association of biological markers of activity of systemic lupus erythematosus with levels of anti-oxidized low-density lipoprotein antibodies.

Gómez-Zumaquero JM, Tinahones FJ, De Ramón E, Camps M, Garrido L, Soriguer FJ.

Rheumatology (Oxford). 2004 Apr;43(4):510-3. Epub 2004 Feb 10.

PMID:
14872100
46.

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejía JC, Aydintug AO, Chwalinska-Sadowska H, de Ramón E, Fernández-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR; European Working Party on Systemic Lupus Erythematosus.

Medicine (Baltimore). 2003 Sep;82(5):299-308.

47.

HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus.

Sebastiani GD, Galeazzi M, Tincani A, Scorza R, Mathieu A, Passiu G, Morozzi G, Piette JC, Cervera R, Houssiau F, Smolen J, Fernandez Nebro A, De Ramon E, Goral AJ, Papasteriades C, Ferrara GB, Carcassi C, Bellisai F, Marcolongo R; European Concerted Action on Immunogenetics of SLE.

Lupus. 2003;12(7):560-3.

PMID:
12892399
48.

Lessons from the "Euro-Lupus Cohort".

Cervera R, Abarca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, Bacarelli MR, Bellisai F, Bernardino I, Biernat-Kaluza E, Blockmans D, Boki K, Bracci L, Campanella V, Camps MT, Carcassi C, Cattaneo R, Cauli A, Chwalinska-Sadowska H, Contu L, Cosyns JP, Danieli MG, D'Cruz D, Depresseux G, Direskeneli H, Domènech I, Espinosa G, Fernández-Nebro A, Ferrara GB, Font J, Frutos MA, Galeazzi M, García-Carrasco M, García-Iglesias MF, García-Tobaruela A, George J, Gil A, González-Santos P, Grana M, Gül A, Haga HJ, de Haro-Liger M, Houssiau F, Hughes GR, Ingelmo M, Jedryka-Góral A, Khamashta MA, Lavilla P, Levi Y, López-Dupla M, López-Soto A, Maldykowa H, Marcolongo R, Mathieu A, Morozzi G, Nicolopoulou N, Papasteriades C, Passiu G, Perelló I, Petera P, Petrovic R, Piette JC, Pintado V, de Pita O, Popovic R, Pucci G, Puddu P, de Ramón E, Ramos-Casals M, Rodríguez-Andreu J, Ruiz-Irastroza G, Sánchez-Lora J, Sanna G, Scorza R, Sebastini GD, Sherer Y, Shoenfeld Y, Simpatico A, Sinico RA, Smolen J, Tincani A, Tokgöz G, Urbano-Márquez A, Vasconcelos C, Vázquez JJ, Veronesi M, Vianni J, Vivancos J; European Working Party on Systemic Lupus Erythematosus.

Ann Med Interne (Paris). 2002 Dec;153(8):530-6.

PMID:
12610427
49.

Clinical benefits of interferon beta-1a in relapsing-remitting MS: a phase IV study.

Fernández O, Arbizu T, Izquierdo G, Martínez-Yélamos A, Gata JM, Luque G, de Ramón E.

Acta Neurol Scand. 2003 Jan;107(1):7-11.

PMID:
12542507
50.

Quality of life in multiple sclerosis patients in Spain.

Chang CH, Cella D, Fernández O, Luque G, de Castro P, de Andrés C, Casanova B, Hernández MA, Prieto JM, Fernández VE, de Ramón E; Grupo Español de Calidad de Vida en Esclerosis Múltiple.

Mult Scler. 2002 Dec;8(6):527-31.

PMID:
12474996

Supplemental Content

Loading ...
Support Center